Chemical Name: ((R)-3-methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid compound with ((R)-3-methyl-1-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid and ((S)-3-methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid and ((S)-3-methyl-1-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid (1:1:1:1)
Analysis of Two Commercially Available Bortezomib Products: Differences in Assay of Active Agent and Impurity Profile
Stephen R. Byrn, Patrick A. Tishmack, Mark J. Milton & Helgi van de Velde
AAPS PharmSciTech volume 12, pages461–467(2011)
Isolation, Solubility, and Characterization of D-Mannitol Esters of 4-Methoxybenzeneboronic Acid
Antonio Lopalco 1 , William A. Marinaro 1 , Victor W. Day 2 , Valentino J. Stella
J Pharm Sci. 2017 Feb;106(2):601-610
Oxidative Deboronation of the Peptide Boronic Acid Proteasome Inhibitor Bortezomib: Contributions from Reactive Oxygen Species in This Novel Cytochrome P450 Reaction
Jason Labutti,† Ian Parsons,‡ Ron Huang, Gerald Miwa, Liang-Shang Gan, and J. Scott Daniels
Chem. Res. Toxicol. 2006, 19, 539-546
